Condition: Vitiligo · Sponsor: Jilin University
The goal of this clinical trial is to investigate the efficacy of upadacitinib after NECS in participants with vitiligo. The main question it aims to answer is: whether the short time use of upadacitinib after NECS will improve NECS efficacy. Participants in the experimental group will receive upadacitinib after NECS, while Participants in the control group will receive NECS only.
This description comes directly from the study's public registry record.
Bing Han · +86 159 4307 3198 · pfk_hanbing@jlu.edu.cn
Always discuss trial participation with your own doctor first.
| Department of Dermatology and Venerology, The First Hospital of Jilin University, No. 1 Xinmin Street | Changchun, Jilin, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06454461